Westlake (WLK) Q2 Profit Drops 104%

Westlake (WLK) reported significantly weaker-than-expected Q2 2025 results, with non-GAAP EPS of $(0.09) and GAAP revenue of $2.95 billion both missing analyst estimates and declining 7.9% year-over-year. Consolidated EBITDA margin sharply contracted from 23% to 12%, primarily driven by continued demand weakness, operational disruptions, and lower pricing, particularly in its Performance and Essential Materials (PEM) segment. The company also incurred $130 million in restructuring charges and posted negative free cash flow. Looking ahead, Westlake plans to normalize chemical production and has expanded its cost reduction program, targeting $350 million in savings by 2026, as it navigates persistent market challenges despite maintaining a strong cash position and investment-grade balance sheet.

Analysis

Westlake Corporation reported a significantly challenging second quarter, marked by substantial misses on both top and bottom lines and a severe contraction in profitability. The company posted a non-GAAP loss per share of $(0.09), a stark reversal from the expected $0.08 profit and a 103.8% year-over-year decline. Revenue of $2.95 billion missed estimates and fell 7.9% from the prior year, reflecting broad-based weakness. The most concerning metric was the collapse in EBITDA margin (excluding identified items), which plummeted to 12% from 23% a year earlier, driven by operational headwinds and weak demand. The Performance and Essential Materials (PEM) segment was the primary source of weakness, with sales dropping 10.9% and swinging to a $188 million operating loss due to a 9% volume decline and plant outages. While the Housing and Infrastructure Products (HIP) segment showed seasonal sequential improvement with sales up 16% from Q1, it still registered a 2.9% year-over-year revenue decline and an 18.2% drop in EBITDA. The company's financial position is stressed, evidenced by negative free cash flow and $130 million in restructuring charges related to plant closures. Despite these pressures, Westlake maintains a strong liquidity position with $2.3 billion in cash, and management has expanded its cost-reduction program, now targeting $350 million in savings by 2026.

Key Decisions for Investors

• Given the severe earnings miss, margin collapse, and negative free cash flow, investors should brace for continued stock price pressure and view the near-term outlook with significant caution.
• The primary catalyst for a potential recovery lies in the Performance and Essential Materials segment; therefore, closely monitor chemical commodity pricing and management's ability to achieve the guided normalization of production rates in the third quarter.
• While the $2.3 billion cash balance provides a buffer, the negative free cash flow and future cash impact of restructuring charges are material risks that could challenge the company's investment-grade balance sheet if operational performance does not improve.
• Management's execution on its upsized $350 million cost-saving initiative is now a critical factor to watch, as it represents the main lever to offset persistent demand weakness and protect profitability.